SEC Form 4 · accession 0001209191-16-130925
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Abdollahian
Officer — Chief Business Officer
Period of report
Jul 1, 2016
Accepted (ET)
Jul 5, 2016 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.45 | Jul 1, 2016 | A | 100,000 | A | — | Jun 30, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of July 1, 2016; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on July 1, 2020.